Charles River Labs (NYSE: CRL) CFO files Form 3 reporting zero stock ownership

Rhea-AI Filing Summary

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. executive Glenn Coleman, the company’s EVP & Chief Financial Officer, filed an initial Form 3 reporting his beneficial ownership of the company’s Common Stock. The filing shows he holds 0 shares directly following the reported holding entry dated April 6, 2026.

Form 3 filings introduce insiders’ starting ownership positions to the market, providing a baseline for any future Form 4 reports of purchases, sales, or equity awards.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Coleman Glenn

Role EVP & Chief Financial Officer

Type	Security	Shares	Price	Value
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 0 shares (Direct)

Footnotes (1)

Key Figures

Direct Common Stock holdings: 0.0000 shares Holding entries reported: 1 entry

2 metrics

Direct Common Stock holdings 0.0000 shares Total shares following holding entry on April 6, 2026

Holding entries reported 1 entry Form 3 summary of insider holdings

Key Terms

Common Stock, EVP & Chief Financial Officer, direct ownership

3 terms

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

EVP & Chief Financial Officer financial

"officer_title: "EVP & Chief Financial Officer""

direct ownership financial

"ownership_type: "direct", ownership_code: "D""

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Coleman Glenn

(Last) (First) (Middle)

C/O CHARLES RIVER LABORATORIES

251 BALLARDVALE ST

(Street)

WILMINGTON MASSACHUSETTS 01887

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/06/2026

3. Issuer Name and Ticker or Trading Symbol
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. [ CRL ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	0	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Glenn Coleman	04/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Glenn Coleman’s Form 3 for CRL report?

The Form 3 for CHARLES RIVER LABORATORIES (CRL) shows EVP & Chief Financial Officer Glenn Coleman reporting his initial beneficial ownership. It indicates he directly holds 0 shares of Common Stock following the reported holding entry on April 6, 2026.

Who is the insider in this CRL Form 3 filing?

The insider is Glenn Coleman, serving as EVP & Chief Financial Officer of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. This Form 3 establishes his baseline beneficial ownership in the company’s Common Stock for future insider reporting.

How many CRL shares does Glenn Coleman report owning?

The filing shows Glenn Coleman with 0.0000 shares of CRL Common Stock directly owned following the reported holding entry. This zero-balance disclosure serves as a starting point for any subsequent Form 4 transactions he may report.

What type of security is covered in Glenn Coleman’s CRL Form 3?

The Form 3 covers Common Stock of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. It records Coleman’s beneficial ownership position in this security class, which is reported as zero shares directly owned after the April 6, 2026 holding entry.

Does this CRL Form 3 show any insider buying or selling?

No insider buying or selling is shown. The entry is classified as a holding, with transaction details marked as unknown and total shares following the transaction reported as 0.0000, indicating only a baseline ownership disclosure, not a trade.